Resources

1 Resources for

painewebber r&d partners l.p.

  • Subscribe to this listing via:
  • RSS
  • Email
Elan Corporation, PLC Acquires Rights To Athena Neurosciences' Diastat Development Program
SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--June 4, 1996-- Athena Neurosciences, Inc. ("Athena")(Nasdaq: ATHN) announced today that Elan Corporation, plc ("Elan") has purchased for six million dollars the rights of PaineWebber R&D Partners III, L.P. (the "Fund") in Athena's Diastat development program.Diastat is a proprietary gel formulation of diazepam intended for rectal...
Tags: Business Wire, Elan Corp. Plc., FINANCE, Investment, Manufacturing, Nasdaq Stock Market Inc., warrant
Research articles 1996-06-04
  • << Previous
  • page 1 of 1
  • Next >>